Bioregenx (BRGX) Cash from Operations (2022 - 2026)
Bioregenx's quarterly Cash from Operations came in at 26629.0 in Q1 2026, down 29.36% year-on-year from 37695.0 in Q1 2025, and down 61.76% quarter-over-quarter from 69636.0 in Q4 2025.
Bioregenx has reported Cash from Operations for 5 years, with the latest figure at 26629.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 29.36% year-over-year to 26629.0; the trailing twelve-month figure through Mar 2026 stood at 27906.0 (up 115.32% YoY), and the FY2025 full-year result was 38972.0, up 112.02% from the prior year.
- Cash from Operations for Q1 2026 stood at 26629.0, down from 69636.0 in the prior quarter.
- The five-year high for Cash from Operations was 69636.0 in Q4 2025, with the low at 649161.0 in Q2 2023.
- Average Cash from Operations over 5 years is 108131.88, with a median of 31196.0 recorded in 2024.
- Year-over-year, Cash from Operations sank 5528.46% in 2023 and jumped 712.94% in 2025.
- Tracing BRGX's Cash from Operations over 5 years: stood at 4364.0 in 2022, then slumped by 5528.46% to 245626.0 in 2023, then surged by 95.37% to 11361.0 in 2024, then jumped by 712.94% to 69636.0 in 2025, then tumbled by 61.76% to 26629.0 in 2026.
- The last three Cash from Operations figures came in at 26629.0 (Q1 2026), 69636.0 (Q4 2025), and 71564.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 106.85 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 122.94 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 97.53 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 43.08 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 109.52 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 84.91 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 26.12 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 54.50 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 26,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,629.00 |
| Mar 31, 2026 | 26,629.00 |
| Dec 31, 2025 | 69,636.00 |
| Dec 31, 2025 | 69,636.00 |
| Sep 30, 2025 | -71,564.00 |
| Sep 30, 2025 | -71,564.00 |
| Jun 30, 2025 | 3,205.00 |
| Jun 30, 2025 | 3,205.00 |
| Mar 31, 2025 | 37,695.00 |
| Mar 31, 2025 | 37,695.00 |
| Dec 31, 2024 | -11,361.00 |
| Dec 31, 2024 | -11,361.00 |
| Sep 30, 2024 | -31,196.00 |
| Sep 30, 2024 | -31,196.00 |
| Jun 30, 2024 | -177,341.00 |
| Jun 30, 2024 | -177,341.00 |
| Mar 31, 2024 | -104,250.00 |
| Mar 31, 2024 | -104,250.00 |
| Dec 31, 2023 | -245,626.00 |
| Dec 31, 2023 | -245,626.00 |
| Sep 30, 2023 | -283,464.00 |
| Sep 30, 2023 | -283,464.00 |
| Jun 30, 2023 | -649,161.00 |
| Jun 30, 2023 | -649,161.00 |
| Mar 31, 2023 | -336,792.00 |
| Mar 31, 2023 | -336,792.00 |
| Dec 31, 2022 | -4,364.00 |
| Dec 31, 2022 | -4,364.00 |
| Sep 30, 2022 | -6,258.00 |
| Sep 30, 2022 | -6,258.00 |
| Jun 30, 2022 | -33,110.00 |
| Jun 30, 2022 | -33,110.00 |
| Mar 31, 2022 | -20,920.00 |
| Mar 31, 2022 | -20,920.00 |